Literature DB >> 3202565

Otologic disease in patients with acquired immunodeficiency syndrome.

D Kohan1, S G Rothstein, N L Cohen.   

Abstract

A 5-year retrospective study evaluating otologic disease in patients with acquired immunodeficiency syndrome (AIDS) was conducted at the New York University Medical Center-Bellevue Hospital Center. Twenty-six patients with documented otologic disease who met the Centers for Disease Control criteria for AIDS were identified and their charts were analyzed according to presenting complaints, physical examination, diagnostic modalities, pathologic condition, management, and outcome. A marked diversity of otologic diseases of varying severity was noted. The majority of patients complained of hearing loss and otalgia during their hospitalization for treatment of AIDS-related opportunistic infections. The most frequent diagnoses were otitis externa, acute otitis media, and otitis media with effusion. Sensorineural hearing loss frequently appeared to be related to ototoxic medications and neurologic infections.

Entities:  

Mesh:

Year:  1988        PMID: 3202565     DOI: 10.1177/000348948809700611

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  14 in total

Review 1.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Mastoiditis, lymphoma, and AIDS.

Authors:  T Lowry; L Raja; A Verghese
Journal:  West J Med       Date:  1998-09

Review 3.  High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patients.

Authors:  A P Riederer; G O Grein; J R Bogner
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

4.  Auditory impairments in HIV-infected individuals in Tanzania.

Authors:  Isaac I Maro; Ndeserua Moshi; Odile H Clavier; Todd A MacKenzie; Robert J Kline-Schoder; Jed C Wilbur; Robert D Chambers; Abigail M Fellows; Benjamin G Jastrzembski; John E Mascari; Muhammad Bakari; Mecky Matee; Frank E Musiek; Richard D Waddell; C Fordham von Reyn; Jay C Buckey
Journal:  Ear Hear       Date:  2014 May-Jun       Impact factor: 3.570

5.  Peripheral Auditory Function in Young HIV-Positive Adults With Clinically Normal Hearing.

Authors:  Christopher E Niemczak; Travis White-Schwoch; Abigail Fellows; Albert Magohe; Jiang Gui; Catherine Rieke; Trent Nicol; Enica R Massawe; Ndeserua Moshi; Nina Kraus; Jay C Buckey
Journal:  Otolaryngol Head Neck Surg       Date:  2021-09-21       Impact factor: 5.591

6.  Cochlear function among HIV-seropositive and HIV-seronegative men and women.

Authors:  Peter Torre; Howard J Hoffman; Gayle Springer; Christopher Cox; Mary Young; Joseph B Margolick; Michael Plankey
Journal:  Ear Hear       Date:  2014 Jan-Feb       Impact factor: 3.570

7.  Auditory neurophysiology reveals central nervous system dysfunction in HIV-infected individuals.

Authors:  Travis White-Schwoch; Albert K Magohe; Abigail M Fellows; Catherine C Rieke; Brandon Vilarello; Trent Nicol; Enica R Massawe; Ndeserua Moshi; Nina Kraus; Jay C Buckey
Journal:  Clin Neurophysiol       Date:  2020-05-22       Impact factor: 3.708

8.  Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men.

Authors:  Helen S Cohen; Christopher Cox; Gayle Springer; Howard J Hoffman; Mary A Young; Joseph B Margolick; Michael W Plankey
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  An analysis of auditory manifestations in a group of adults with AIDS prior to antiretroviral therapy.

Authors:  Katijah Khoza-Shangase
Journal:  Afr J Infect Dis       Date:  2011

10.  Audio-vestibular function in human immunodeficiency virus infected patients in India.

Authors:  Suma Susan Mathews; Rita Ruby Albert; Anand Job
Journal:  Indian J Sex Transm Dis AIDS       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.